GovChime
Notice ID: 8fc22c111bc84d0a9f7f95b421cf47c6Combined Synopsis/SolicitationArchived

6505--Trastuzumab and Biosimilars (VA-25-00052526)

Archived on September 6, 2025. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
2:30 PM CDT
Posted
July 8, 2025
Notice type
Combined Synopsis/Solicitation
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Veterans Affairs

Notice details

Office
NAC PHARMACEUTICALS (36E797)
Place of performance
P.O. BOX 76, Hines, 60141
Last updated
Nov 12, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
36E79725R0038
Notice ID
8fc22c111bc84d0a9f7f95b421cf47c6

Description

Trastuzumab and Biosimilars (VA-25-00052526)

Full description on SAM.gov

Award Overview

Possible prior contract

Inferred, not confirmed

Inferred, not confirmed. Matched by agency, NAICS, place of performance and end-date proximity. This is a candidate, not the contractor of record.

Contract end date

Jul 31, 2025

NAICS

325412

Agency

Department of Veterans Affairs

Dollar amounts are not shown for inferred matches because the link is heuristic. Open the award below to check it.

Contacts

Contracting Officer

Primary Contact

Anthony.DiCrescenzo
Contract Specialist

Documents

Files (4)

  • 36E79725R0038 0001.docx

    114 KBAdded in Combined Synopsis/Solicitation version 4Posted
    Download
  • 36E79725R0038 - final.docx

    321 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • 36E79725R0038_4.docx

    14 KBAdded in Combined Synopsis/Solicitation version 2Posted
    Download
  • 36E79725R0038_1.docx

    25 KBAdded in Presolicitation version 4Posted
    Download
  • About Us
    department.va.govPosted

Lifecycle

  1. 6
    Version 6PresolicitationArchived

    6505--Trastuzumab and Biosimilars

    Notice 4b4a7b65285a48b69426c97ede3d94f6 on SAM.gov

  2. 2
    Version 2Combined Synopsis/SolicitationArchived

    Type changed from Presolicitation to Combined Synopsis/Solicitation

    6505--Trastuzumab and Biosimilars (VA-25-00052526)

    Notice 00d4073898f94e27bd7e54e2a2069cb2 on SAM.gov

  3. 4
    Version 4Combined Synopsis/SolicitationArchivedCurrent

    6505--Trastuzumab and Biosimilars (VA-25-00052526)

    Notice 8fc22c111bc84d0a9f7f95b421cf47c6 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

36E79725R0038

Archive Date

Sep 6, 2025